-
Security Type
-
Convertible Note
-
Min Investment
-
$100
-
Offering Date
-
June 18, 2021
-
Target Raise
-
$50.00K
Company Description
The platform technology now used by Hera Diagnostics was born as part of the dissertation project of Dr. Jesús Seañez under the guidance of Dra. Olivia Barron and Dr. Noél Leon. As the father of three young girls, Jesus was inspired to create a diagnostic tool for cervical cancer that would improve on the current solution, the Pap Smear. As an outdated and uncomfortable modality, the pap smear doesn’t meet the needs of enough women.
Through his research, Jesus created a tool that is not only reliably accurate, but prioritizes comfortable and convenient health services for female patients.
Key Deal Facts
Over 300,000 women die annually from cervical cancer even though the disease is easily treatable.
90% of cervical cancer deaths occur in underserved populations globally.
Hera will reduce those deaths by delivering high-tech screening to low-tech communities.
Our device is portable, accurate, affordable, painless and gives real time, point-of-care results.
Phase 1 begins 2021: Mexico then Chile, Peru, Colombia, Brazil, Argentina, Bolivia, China, India.
Projected annual revenues exceed $100M in our phase 1 markets alone.
Hygienic protective sleeves generate attractive recurring revenue streams for each deployed device.
Team is composed of talented women, LatinX technologists and proven company builders.
Management Team / Advisory Board Bios
Teo Tijerina, CEO
Bilingual Spanish/English well-rounded executive with a career trajectory that spans organizational leadership, business development, marketing, corporate management, entrepreneurship, manufacturing, and innovation.
Delaney Dunn Dichoso, COO & General Counsel
Delaney’s career background and experience is varied in a multitude of areas including law, business development, operations, HR, tech, and healthcare. As a result she excels in hybrid positions that encompass legal and strategy responsibilities.
Jesus Seanez, Chief Technology Officer
As a biomedical engineer, Jesus has the fundamental knowledge to launch the integration of existing technologies, as well as launch those that need to be improved and those that are yet to be created.
